Axsome Thera
(AXSM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 86,473 | 114,623 | 141,219 | 164,660 | 183,876 |
| TOTAL | $86,518 | $115,024 | $141,655 | $165,035 | $184,025 |
| Non-Current Assets | |||||
| PPE Net | 284 | 315 | 83 | 74 | 53 |
| Other Non-Current Assets | 983 | 1,259 | 1,527 | 1,794 | 2,057 |
| TOTAL | $1,267 | $1,574 | $1,610 | $1,868 | $2,110 |
| Total Assets | $87,785 | $116,599 | $143,265 | $166,904 | $186,134 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,149 | 13,382 | 11,612 | 14,622 | 13,504 |
| Accrued Expenses | 9,295 | 10,445 | 10,163 | 5,865 | 8,713 |
| TOTAL | $23,065 | $24,707 | $22,864 | $21,683 | $23,438 |
| Non-Current Liabilities | |||||
| Long Term Debt | 49,090 | 49,174 | 48,883 | 48,598 | 48,322 |
| Other Non-Current Liabilities | 0 | 0 | 82 | 330 | 582 |
| TOTAL | $49,090 | $49,174 | $48,965 | $48,928 | $48,904 |
| Total Liabilities | $72,155 | $73,881 | $71,828 | $70,611 | $72,341 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,477 | 37,692 | 37,682 | 37,570 | 37,405 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -409,199 | -375,223 | -340,340 | -308,056 | -278,796 |
| TOTAL | $15,630 | $42,718 | $71,437 | $96,293 | $113,793 |
| Total Liabilities And Equity | $87,785 | $116,599 | $143,265 | $166,904 | $186,134 |